Preoperative Anxiety and Surgical Fear in Holmium Laser Enucleation of the Prostate and Transurethral Resection of the Prostate Patients With Benign Prostatic Hyperplasia

NCT07663097 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2026-06-26

No results posted yet for this study

Summary

Benign prostatic hyperplasia (BPH) is a common condition in older men and may cause bothersome lower urinary tract symptoms that can negatively affect quality of life. Surgical treatment with Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) is often recommended when medical therapy is insufficient.

This prospective observational study aims to evaluate whether preoperative anxiety, depression, and surgical fear influence postoperative functional outcomes, urinary continence, erectile function, and patient satisfaction in patients undergoing HoLEP or TURP for BPH. Participants will complete validated psychological and functional questionnaires before surgery and during postoperative follow-up visits at 1 and 3 months. The study will also assess changes in psychological status after surgery and compare outcomes between HoLEP and TURP patients.

The findings may help improve preoperative patient counseling and identify patients who could benefit from additional psychological support before surgery.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

PROCEDURE

Holmium Laser Enucleation of the Prostate (HoLEP)

Standard HoLEP procedure for treatment of benign prostatic hyperplasia.

PROCEDURE

Transurethral Resection of the Prostate (TURP)

Standard TURP procedure for treatment of benign prostatic hyperplasia.

Sponsors & Collaborators

  • Hitit University

    lead OTHER

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-14
Primary Completion
2027-04-08
Completion
2027-06-08

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07663097 on ClinicalTrials.gov